Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sinovac Biotech Ltd (NASDAQ:SVA)

5.96
Delayed Data
As of Jul 22
 +0.01 / +0.17%
Today’s Change
4.38
Today|||52-Week Range
7.16
+4.20%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Revenue and IncomeNet Revenues18.5M16.8M23.0M11.0M
 
 
 
 
 
Cost of Goods Sold1.6M3.9M6.0M3.2M
 
 
 
 
 
Depreciation And Amortization1.8M1.7M1.3M1.4M
 
 
 
 
 
 
Operating ExpensesGross Income15.1M11.2M15.7M6.3M
 
 
 
 
 
General Expenses11.6M12.7M14.0M8.5M
 
 
 
 
 
Research And Development2.2M2.2M2.9M2.1M
 
 
 
 
 
Total Operating Expenses15.0M18.4M21.3M13.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income3.5M-1.6M1.7M-2.2M
 
 
 
 
 
Interest Expense On Debt421.0K493.0K418.0K383.0K
 
 
 
 
 
Other Expenses489.0K100.0K991.0K646.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income3.9M-1.7M2.5M-1.6M
 
 
 
 
 
Income Taxes-440.0K-267.0K-1.3M-52.0K
 
 
 
 
 
Minority Interest-1.2M-382.0K-651.0K-560.0K
 
 
 
 
 
Discontinued Operations0.000.00-109.0K2.3M
 
 
 
Net Income2.3M-1.6M504.0K1.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS56.0M56.4M56.9M56.9M
 
 
 
 
 
Shares To Calculate EPS Diluted56.2M56.4M57.0M57.0M
 
 
 
 
 
 
Earnings Per ShareEPS$0.04-$0.03$0.01$0.02
 
 
 
 
 
EPS Diluted$0.04-$0.03$0.01$0.02